Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
96.13
+0.62 (0.65%)
Nov 20, 2026, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.28 billion as of November 20, 2026. It is the 2,886th most valuable company in the world and the 954th biggest in the United States. Its market cap has increased by 73.36% in one year.
Market Cap
6.28B
Enterprise Value
6.65B
1-Year Change
73.36%
Global Rank
Country Rank
#954 United States
Category
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.28B, an increase of 2,011.37%. That is a compound annual growth rate of 51.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.28B | 53.72% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 7.04B |
| Corcept Therapeutics | 6.96B |
| Axsome Therapeutics | 6.80B |
| Immunovant | 6.57B |
| Oruka Therapeutics | 6.50B |
| ImmunityBio | 6.40B |
| Kodiak Sciences | 6.34B |
| ABIVAX Société Anonyme | 6.03B |